Home LiteratureArticle Details
PMID: 20501854 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Breast cancer dormancy can be maintained by small numbers of micrometastases.

Cancer research ·Vol. 70 ·No. 11 ·2010-06-01 ·Pages 4310-7

Willis L, Alarcón T, Elia G, Jones JL, Wright NA, Tomlinson IP, Graham TA, Page KM

Abstract

Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the intervening years between initial treatment and relapse, occult cancers are maintained in an apparent state of dormancy that is poorly understood. In this study, we applied a probabilistic mathematical model to long-term follow-up studies of postresection patients to investigate the factors involved in mediating breast cancer dormancy. Our results suggest that long-term dormancy is maintained most often by just one growth-restricted dangerous micrometastasis. Analysis of the empirical data by Approximate Bayesian Computation indicated that patients in dormancy have between 1 and 5 micrometastases at 10 years postresection, when they escape growth restriction with a half-life of <69 years and are >0.4 mm in diameter. Before resection, primary tumors seed at most an average of 6 dangerous micrometastases that escape from growth restriction with a half-life of at least 12 years. Our findings suggest that effective preventive treatments will need to eliminate these small numbers of micrometastases, which may be preangiogenic and nonvascularized until they switch to growth due to one oncogenic mutation or tumor suppressor gene inactivation. In summary, breast cancer dormancy seems to be maintained by small numbers of sizeable micrometastases that escape from growth restriction with a half-life exceeding 12 years.

MeSH Terms
Bayes Theorem Breast Neoplasms/genetics,pathology,surgery Female Humans Models, Biological Models, Statistical Mutation Neoplasm Metastasis
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Willis Lisa
CoMPLEX, University College London, London, United Kingdom. l.willis@ucl.ac.uk
Alarcón Tomas
Elia George
Jones J Louise
Wright Nick A
Tomlinson Ian P M
Graham Trevor A
Page Karen M
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2010-06-01
Epub
2010-00-25
Pages
4310-7
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
Cancer Research UK · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com